Online citations, reference lists, and bibliographies.

UALCAN: A Portal For Facilitating Tumor Subgroup Gene Expression And Survival Analyses1

Darshan S. Chandrashekar, Bhuwan Bashel, S. A. H. Balasubramanya, C. Creighton, I. Ponce-Rodriguez, B. Chakravarthi, S. Varambally
Published 2017 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Genomics data from The Cancer Genome Atlas (TCGA) project has led to the comprehensive molecular characterization of multiple cancer types. The large sample numbers in TCGA offer an excellent opportunity to address questions associated with tumo heterogeneity. Exploration of the data by cancer researchers and clinicians is imperative to unearth novel therapeutic/diagnostic biomarkers. Various computational tools have been developed to aid researchers in carrying out specific TCGA data analyses; however there is need for resources to facilitate the study of gene expression variations and survival associations across tumors. Here, we report UALCAN, an easy to use, interactive web-portal to perform to in-depth analyses of TCGA gene expression data. UALCAN uses TCGA level 3 RNA-seq and clinical data from 31 cancer types. The portal's user-friendly features allow to perform: 1) analyze relative expression of a query gene(s) across tumor and normal samples, as well as in various tumor sub-groups based on individual cancer stages, tumor grade, race, body weight or other clinicopathologic features, 2) estimate the effect of gene expression level and clinicopathologic features on patient survival; and 3) identify the top over- and under-expressed (up and down-regulated) genes in individual cancer types. This resource serves as a platform for in silico validation of target genes and for identifying tumor sub-group specific candidate biomarkers. Thus, UALCAN web-portal could be extremely helpful in accelerating cancer research. UALCAN is publicly available at http://ualcan.path.uab.edu.
This paper references
10.1016/j.molcel.2015.05.004
High-throughput sequencing technologies.
Jason A. Reuter (2015)
10.1038/nature11252
Comprehensive Molecular Characterization of Human Colon and Rectal Cancer
D. M. Muzny (2012)
10.1016/j.ccell.2016.07.013
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
S. Zheng (2016)
10.1038/nature20805
Integrated genomic characterization of oesophageal carcinoma
Bc Cancer Agency (2017)
10.1016/j.cell.2015.05.044
Genomic Classification of Cutaneous Melanoma
Rehan Akbani (2015)
10.1038/nature13480
Comprehensive molecular characterization of gastric adenocarcinoma
A. Bass (2014)
10.1038/nature11404
Comprehensive genomic characterization of squamous cell lung cancers
P. Hammerman (2012)
10.1038/NATURE12965
Comprehensive molecular characterization of urothelial bladder carcinoma
J. Weinstein (2014)
10.1186/1471-2105-12-323
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li (2011)
10.1016/j.cell.2014.09.050
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
N. Agrawal (2014)
10.1038/nature14129
Comprehensive genomic characterization of head and neck squamous cell carcinomas
M. Lawrence (2015)
survminer: Drawing Survival Curves using 'ggplot2
A Kassambara (2017)
KEGG.db: A set of annotation maps for KEGG
M Carlson (2016)
10.1158/0008-5472.CAN-15-0273
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.
Jun Li (2015)
10.1371/journal.pone.0085621
Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project
Christopher J. Ricketts (2014)
10.1016/j.cell.2015.09.033
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello (2015)
10.1172/JCI45014
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D. Lehmann (2011)
DNAmicroarrays: a powerful genomic tool for biomedical and clinical
V Trevino (2007)
10.1016/j.ccell.2017.01.001
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
L. Fishbein (2017)
10.1038/nature12113
Integrated Genomic Characterization of Endometrial Carcinoma
D. Levine (2013)
10.2119/2006-00107.Trevino
DNA Microarrays: a Powerful Genomic Tool for Biomedical and Clinical Research
V. Treviño (2007)
10.1016/j.rmed.2014.11.004
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Seth A Brodie (2015)
10.1038/nature11412
Comprehensive molecular portraits of human breast tumors
D. Koboldt (2012)
10.1126/science.1260419
Tissue-based map of the human proteome
M. Uhlén (2015)
10.1016/J.YPAT.2012.10.013
Comprehensive molecular portraits of human breast tumours
Andrew McCullough (2013)
Heterogeneity and cancer.
K. Allison (2014)
10.1016/j.cell.2015.10.025
The Molecular Taxonomy of Primary Prostate Cancer
Adam A Abeshouse (2015)
10.1016/S1476-5586(04)80047-2
ONCOMINE: a cancer microarray database and integrated data-mining platform.
D. Rhodes (2004)
10.5732/cjc.014.10117
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
Wei Zhang (2014)
10.1056/NEJMoa1505917
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
W. Linehan (2016)
10.1038/nature07385
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R. McLendon (2008)
KEGG.db: A set of annotation maps for KEGG. R package version 3.1.2
M Carlson (2016)
10.1186/1471-2407-14-970
PROGgeneV2: enhancements on the existing database
Chirayu Pankaj Goswami (2014)
10.5114/wo.2014.47136
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak (2015)
10.1038/nature12965
Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma
The Cancer Genome Atlas Research Network (2014)
10.1371/journal.pone.0106397
RTCGAToolbox: A New Tool for Exporting TCGA Firehose Data
Mehmet Kemal Samur (2014)
10.1093/bioinformatics/btw830
GDISC: a web portal for integrative analysis of gene‐drug interaction for survival in cancer
John Christian Givhan Spainhour (2017)
survminer: Drawing Survival Curves using 'ggplot2'. R package version 0.3.1
A Kassambara (2017)
10.1186/s13073-015-0226-3
The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical–genomic driver associations
HoJoon Lee (2015)
10.1038/nmeth.2956
TCGA-Assembler: open-source software for retrieving and processing TCGA data
Yitan Zhu (2014)
10.1093/nar/gks1168
miRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting
Sooyoung Cho (2013)
10.1055/s-0041-106169
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
I Peters (2015)
10.1074/mcp.T500003-MCP200
Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma*
K. Sheehan (2005)
10.4137/CIN.S9983
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Xiao Dong Chen (2012)
10.1371/journal.pmed.1000279
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
F. Blows (2010)
10.1038/nature21386
Integrated genomic and molecular characterization of cervical cancer
R. Burk (2017)
10.1158/2159-8290.CD-12-0095
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
E. Cerami (2012)
10.1593/neo.07112
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.
D. Rhodes (2007)
10.1186/s12864-016-2852-6
ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer
In Seok Yang (2016)
DNAmicroarrays : a powerful genomic tool for biomedical and clinical research
V Trevino (2007)
10.1055/S-0041-106169
Implikationen der TCGA Netzwerkdaten für Zweit-Generations-Immuntherapiekonzepte auf Basis der PD-L1 und PD-1 Zielstrukturen
Ilona Peters (2015)
10.1038/sj.bjc.6601119
Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods
M. Bradburn (2003)
10.7554/eLife.05005
Predicting effective microRNA target sites in mammalian mRNAs
V. Agarwal (2015)
10.1126/scisignal.2004088
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
J. Gao (2013)
10.1016/j.cell.2015.12.028
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli (2016)
10.1093/bioinformatics/btp692
RNA-Seq gene expression estimation with read mapping uncertainty
Bo Li (2010)
10.1056/NEJMoa1301689
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
T. Ley (2013)
A Package for Survival Analysis in S
T. Therneau (1994)
10.1038/nature13385
Comprehensive molecular profiling of lung adenocarcinoma
E. Lander (2014)



This paper is referenced by
10.3389/fmolb.2019.00098
MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers
Min Jiang (2019)
10.1038/s41467-020-15905-6
Protein-altering germline mutations implicate novel genes related to lung cancer development
Xuemei Ji (2020)
10.7150/jca.23662
MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer
Xiangxiang Liu (2018)
10.7150/ijbs.29048
GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway
Yingge Mao (2019)
10.7717/peerj.8182
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
Jiangfen Li (2019)
10.3390/ph12040181
Prostate-Derived ETS Factor (PDEF) Modulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling
Praveen Kumar Jaiswal (2019)
10.1155/2020/6034670
Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer
Zhao Zhang (2020)
Abstract. The aim of the present study was to determine the role of nucleolar and spindle-associated protein 1 (NuSAP1) in human liver cancer. NuSAP1 expression was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), western blotting and immunohistochemistry in hepa
YIFAN WANG (2019)
10.1186/s12935-020-01442-1
USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer
F. Huang (2020)
10.7150/jca.45604
The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment
Xu Lin (2020)
10.1080/21691401.2018.1553783
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF
Hu Zhao (2019)
10.1038/s41467-019-13528-0
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
F. Chen (2019)
10.1016/j.redox.2020.101578
C/EBPβ mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation
Kecheng Lei (2020)
10.1007/s13721-020-00250-x
Evaluation of the prognostic significance of CDK6 in breast cancer
Jeba Afifa Zinia (2020)
10.1016/j.canlet.2018.08.024
LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Yuqi Huang (2018)
10.1038/s41598-020-68713-9
Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
Dilireba Bolidong (2020)
10.1002/cpmb.49
Making Use of Cancer Genomic Databases.
Chad J. Creighton (2018)
10.3233/CBM-190013
E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
Kirti Gondkar (2019)
10.7717/peerj.7197
Screening of immunosuppressive factors for biomarkers of breast cancer malignancy phenotypes and subtype-specific targeted therapy
P. Wang (2019)
10.2147/CMAR.S202342
Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation
Chunji Quan (2019)
10.2147/CMAR.S218926
Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
Zhao Wang (2019)
10.3892/mmr.2019.10644
CFHR1 is a potentially downregulated gene in lung adenocarcinoma
Geting Wu (2019)
10.21037/atm.2019.11.32
Relationship between NAMPT/PBEF/visfatin and prognosis of patients with malignant tumors: a systematic review and meta-analysis.
Chengjian Ji (2019)
10.3389/fgene.2019.01380
Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme
Runzhi Huang (2019)
10.21037/atm-20-3296
Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia.
Jie Wei (2020)
10.1038/s41598-019-50865-y
Expression and gene regulation network of INHBA in Head and neck squamous cell carcinoma based on data mining
Zenghong Wu (2019)
OTT_A_240642 1941..1951
Xuebing Wang (2020)
10.1038/s41419-020-2585-y
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy
B. Montico (2020)
10.1016/j.retram.2019.08.003
Expression and clinical significance of CPS1 in glioblastoma multiforme.
Geting Wu (2019)
10.1186/s12935-020-01315-7
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers
J. Chen (2020)
10.18632/aging.102991
PCNA-associated factor KIAA0101 transcriptionally induced by ELK1 controls cell proliferation and apoptosis in nasopharyngeal carcinoma: an integrated bioinformatics and experimental study
H. Zhao (2020)
10.1016/j.ygyno.2019.04.005
Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
X. Xu (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar